Products

Rhubarb Liquid Extract Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Rhubarb Liquid Extract Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 596453
    Product Name Rhubarb Liquid Extract Veterinary Grade API
    Product Type Liquid Extract for Veterinary Use
    Api Grade Veterinary Grade API
    Plant Source Rheum officinale and/or Rheum palmatum rhizomes and roots
    Dosage Forms Compatible Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Appearance Dark brown to brownish-black clear to slightly viscous liquid
    Odor Characteristic aromatic herbal odor
    Solubility Freely soluble in water and miscible with hydroalcoholic blends
    Active Constituents Anthraquinone glycosides including rhein, emodin, chrysophanol, and aloe-emodin
    Ph Range 5.0 to 7.0
    Specific Gravity 1.02 to 1.10 at 25°C
    Microbial Limit Total bacterial count less than 1000 CFU/mL; total fungi less than 100 CFU/mL; free from Salmonella and Escherichia coli
    Solvent Vehicle Purified water with permitted pharmaceutical ethanol as preservative
    Storage Conditions Store in tightly closed containers protected from light at 15 to 25°C
    Shelf Life 24 months when stored under recommended conditions

    As an accredited Rhubarb Liquid Extract Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Veterinary grade liquid extract packaged in 25 L HDPE drums, nitrogen-sealed with tamper-evident closure, labeled and supplied with batch certificate.
    Container Loading (20′ FCL) 20′ FCL container loading of Rhubarb Liquid Extract Veterinary Grade API, securely packed for tablets, injections, capsules, powders, granules, premix, and solutions.
    Shipping Ship in sealed, light-resistant containers to maintain stability. Protect from extreme temperatures and moisture. Label as veterinary-grade API for non-human use. Adhere to international transport regulations, including hazardous material documentation if applicable. Include safety data sheets and certificates of analysis. Use temperature-controlled logistics where required to ensure product integrity.
    Storage Store in tightly sealed, light-resistant containers in a cool, dry place. Maintain temperature between 2–8°C or per label, avoiding freezing and direct sunlight. Ensure container is protected from moisture and contamination, and check for sediment or odor changes before use.
    Shelf Life Shelf life is typically 24 months when stored tightly sealed in original containers, protected from light, moisture, and temperatures below 25°C.
    Application of Rhubarb Liquid Extract Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    In tablet production, the rhubarb liquid extract veterinary grade API is rarely direct-compressed; it is first converted to a free-flowing granulation mixture. The incoming hydroalcoholic extract is standardised against Ph. Eur. Rhei radix to a minimum of 2.2% hydroxyanthracene derivatives calculated as rhein, with ethanol content between 25% and 55%. A common industrial route is wet granulation in a high-shear mixer with a 25 L bowl and three-blade impeller. The API is blended with microcrystalline cellulose and maize starch at a ratio of 1:2:1, w/w, before the liquid extract is added as the granulating fluid at 10–15% w/w of the dry blend. The hydroxyanthracene content of the dried granulate is adjusted to 15–20 mg rhein per 1 g granulate for a 4 g swallowable horse tablet. Granulation endpoint is monitored by impeller torque increase of 15–20 N·m above dry-mix baseline, preventing overwetting that causes the rhein fraction to migrate to the granule surface. Drying in a fluid-bed dryer is maintained below 55°C inlet temperature to limit browning of tannin-rich fractions. Tablet compression is performed on a rotary press equipped with 18 mm oval punches and compression force between 8 kN and 12 kN, producing tablets with hardness of 70–90 N and friability below 1.0% according to Ph. Eur. 2.9.7. Disintegration testing per Ph. Eur. 2.9.1 in water at 37°C typically yields times under 15 min when croscarmellose sodium at 3% w/w is incorporated. Dissolution of rhein from these tablets is pH-dependent; the use of USP <711> apparatus 2 at 50 rpm in pH 6.8 phosphate buffer is more discriminative than 0.1 N HCl because anthraquinone aglycones remain poorly soluble at gastric pH. Published data for this specific configuration is limited, but the described granulation ratio and drying ceiling derive from standard wet-granulation practice for hygroscopic plant-extract APIs.

    What Limits Direct Injection of Rhein-Containing Extracts into Multidose Vials for Cattle?

    Parenteral formulation of rhein-containing extracts is constrained by the low aqueous solubility of anthraquinone aglycones below pH 7.0 and by the potential haemolytic activity of co-solvents at high concentration. A conventional preparation method uses not more than 15% v/v propylene glycol and 10% v/v PEG 400 in water for injection, with pH adjusted to 7.4–7.6 using trometamol. The liquid extract, after evaporation of ethanol under reduced pressure at 40°C, is incorporated at a ratio equivalent to 2 mg hydroxyanthracene derivatives per mL. The solution is passed through a 0.22 µm polyethersulfone membrane filter before filling; terminal steam sterilisation at 121°C for 15 min is avoided because anthraquinone glycosides may degrade and produce dark-coloured aglycone precipitates. Bacterial endotoxin control follows Ph. Eur. 2.6.14 with a limit of less than 0.5 EU/mg of dry extract, and particulate matter is assessed by USP <788> allowing not more than 6000 particles of 10 µm or greater per container. The injectable route is not the default veterinary administration mode for rhubarb; its use is limited to veterinarian-directed compounding where oral administration is impossible. Published data for this specific configuration is limited, and batch-to-batch variation in tannin content can shift the pH of unbuffered solutions by 0.5 pH units.

    Capsule filling with rhubarb extract requires a moisture-controlled intermediate with a particle-size range suitable for automatic encapsulation. The liquid extract is absorbed onto a 1:1 w/w mixture of maltodextrin and colloidal silicon dioxide at 15% w/w liquid extract loading, then dried at 40°C under vacuum to a loss on drying below 5.0% per Ph. Eur. 2.2.32. The resulting powder is milled through a 0.8 mm screen and blended with 1% w/w magnesium stearate for 3 min in a 500 L double-cone blender. Flowability is monitored by the pharmacopoeial method for bulk and tapped density; a Hausner ratio above 1.35 indicates poor flow and is corrected by increasing colloidal silicon dioxide to 2% w/w. Hard gelatin capsules for companion animals are filled on a semi-automatic encapsulator with dosing tamp pins at 60 cycles/min to a target fill weight of 350 mg, delivering 25–30 mg hydroxyanthracene derivatives per capsule. Dissolution is evaluated in pH 6.8 phosphate buffer using USP <711> apparatus 1 at 100 rpm; two-stage dissolution with 0.1 N HCl for 2 h followed by pH 6.8 buffer is also used to screen for over-dependence on enteric pH. Hydroxyanthracene assay by Ph. Eur. 2.2.27 thin-layer chromatography is used for batch release. Published data for this specific configuration is limited.

    Release testMethodAcceptance limitEquipment
    Hydroxyanthracene contentPh. Eur. 2.2.27≥ 15 mg/gTLC scanner
    Loss on dryingPh. Eur. 2.2.32≤ 5.0%Halogen moisture analyser
    Total ashPh. Eur. 2.4.16≤ 12.0%Muffle furnace at 550°C
    Bacterial endotoxinsPh. Eur. 2.6.14< 0.5 EU/mgLAL reader
    Particulate matterUSP <788>≤ 6000 particles of ≥ 10 µm per containerLight obscuration particle counter
    Residual ethanolVICH GL18≤ 5000 ppmGas chromatograph

    Dry Premix Stability in Mineral-Rich Ruminant Feed

    Mineral-rich carrier systems introduce a pH-buffering effect that can destabilise rhein when the premix is stored above 25°C. A typical medicated premix is produced by depositing the liquid extract onto a carrier of wheat bran and calcium carbonate at a ratio of 4:1, with liquid extract added at 8% w/w in a twin-shaft paddle mixer operating at 50 rpm for 12 min. The terminal premix is diluted at 2–5 kg per tonne of complete feed, with the final milligram-per-kg dosage fixed by the prescribing veterinarian because published species-specific dose requirements are limited. Mixing uniformity is assessed by collecting 10 samples from the mixer discharge and calculating the coefficient of variation of rhein content, with an acceptance limit of less than 5.0%. The equipment must be cleaned between batches because rhubarb tannins coat stainless steel surfaces and react with iron residues; rinse water pH is adjusted to 4.0 with citric acid before cleaning. Moisture is controlled to below 10% by weight to reduce mould growth. Compliance with medicated feed requirements follows FDA 21 CFR 225 for building and process controls, while residual ethanol is controlled under VICH GL18 with a class 3 limit of 5000 ppm. The finished feed is not sterilised; therefore the premix is consumed within 14 days of mixing in hot, humid conditions.

    Hard Water Alkalinity Limits Rhein Solubility in Poultry Drinking-Water Systems

    Drinking-water administration presents a pH and hardness problem: anthraquinone aglycones are poorly soluble in water at neutral pH, and tannins form insoluble complexes with calcium and magnesium ions. Water hardness is measured by EDTA titration per ISO 6058; when total hardness exceeds 200 mg/L CaCO₃, the stock solution is acidified with citric acid to pH 4.0–4.5 before adding the rhubarb extract. A typical stock solution is prepared at 10 g extract per 10 L water in a 200 L dosing tank, then injected by a diaphragm pump into the drinking line at 1.0–2.5% v/v. In-line mixing is achieved with a static mixer of 12 elements; without shear, the viscous extract forms a raft on the water surface. The stock solution must be used within 12 h if no preservative is present, because microbial growth reduces rhein content and raises endotoxin load. The diluted drinking water is sampled at the drinker outlets and checked for visible precipitate after passage through a 0.45 µm membrane filter; any filter blockage indicates hard-water complexation. pH is re-checked with a handheld meter at each sampling point. VICH GL18 residual ethanol limits are evaluated on the stock solution; co-solvents used in the extract can raise final water ethanol concentration if improperly diluted.

    Fluid-bed conversion of the liquid extract into granulated intermediates allows direct incorporation into feed without the dust exposure associated with fine powders. The liquid extract is diluted with purified water to 50% v/v and sprayed onto a fluidised charge of maltodextrin and maize starch at 60:40 w/w in a top-spray fluid-bed granulator with a 40 L product bowl. Inlet air temperature is held between 45°C and 55°C, product temperature at 30–35°C, and atomising pressure at 2.0–2.5 bar. Spray rate is limited to 8–12 g/min per kg of substrate to prevent surface overwetting, because the extract contains sugars and tannins that convert granules into a cohesive mass. The granulation endpoint is determined by a product moisture of 2.0–3.0% as measured by loss on drying per Ph. Eur. 2.2.32. The dried granules are sieved through a 1.0 mm screen and the 0.5–1.0 mm fraction is retained for packaging; undersized fines are re-granulated. Terminal feed granules are packed in foil-lined multi-wall paper bags with oxygen transmission below 0.5 cm³/m²/day. This packaging limits oxidative darkening of the anthraquinone fraction during six-month storage.

    When a Drench Solution Is Compounded Without a Routine Stability Study

    A drench solution prepared on-farm or in a veterinary practice does not have the same stability data as a registered premix. Under these conditions, the extract is diluted at 1:50 in potable water and administered within 2 h of mixing; longer holding is not recommended because non-sterile potable water introduces bioburden. Sodium benzoate at 0.1% w/v and potassium sorbate at 0.1% w/v may be added only if the pH is below 4.5; above this pH, the preservatives are largely ineffective. The solution is drawn into a 60 mL drenching gun with a flexible nozzle and delivered orally to sheep or calves. Rinsing the gun with 0.1% w/v citric acid solution after use delays polymerised tannin buildup in the barrel, which is a common cause of nozzle blockage. If a uniform suspension is required because rhein aglycones settle, 0.5% w/v xanthan gum is added under high-shear mixing at 3000 rpm for 5 min. Because no sterile filtration is applied, endotoxin load is checked by LAL assay per Ph. Eur. 2.6.14 on each batch; counts above 0.5 EU/mg of dry extract are rejected for drenching of neonatal animals. Published data for this specific configuration is limited.

    A whole-food top dressing powder for equines is prepared by direct blending of the extract with a non-hygroscopic carrier system, rather than by granulation. The carrier comprises ground oat hulls, calcium carbonate and fumed silica at a ratio of 80:15:5 w/w; liquid extract is sprayed onto the blend at 6% w/w in a plow mixer with choppers running at 1500 rpm for 8 min. The high-shear choppers are required to break up extract-enriched lumps that form when the liquid first contacts the fine carrier. The final powder is passed through a 500 µm sieve before filling into 2 kg HDPE tubs. Moisture is controlled below 8% w/w, and the tubs are heat-sealed with aluminium induction seals. Assay uniformity is confirmed by taking 20 stratified samples and comparing rhein content by Ph. Eur. 2.2.27; the acceptance criterion is a relative standard deviation below 5.0%. The product is top-dressed onto feed at 50 g per 500 kg body mass once daily, but actual dosing is determined by the veterinarian. Palatability is evaluated by a 30-min refusal test in horses; addition rates above 75 g per 500 kg body mass are frequently refused because of the astringent tannin aftertaste.

    Free Quote

    Competitive Rhubarb Liquid Extract Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Rhubarb Liquid Extract Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions (Model RVLE-VG-01) is a standardized hydroethanolic extract derived from the root and rhizome of *Rheum palmatum* L. or *Rheum officinale* Baill., processed by closed-loop percolation with 70% v/v ethanol and concentrated under vacuum at ≤60°C to a total solids range of 25.0–30.0% w/w. The extraction solvent is subsequently recovered under reduced pressure, leaving an ethanol residue below 0.5% w/w in the final liquid. The extract is specified for formulation into solid, semi-solid, and liquid veterinary dosage forms, including compressed tablets, injectable solutions, hard and soft capsules, oral powders, granules for feed or drinking water, medicated premixes, and oral drenches or solutions. Its pharmacologically active fraction comprises anthraquinone aglycones and glycosides—rhein, emodin, chrysophanol, aloe-emodin, and physcion—alongside tannins and dianthrone glycosides. Unlike unstandardized rhubarb powder, whose total anthraquinone content fluctuates with harvest geography, root age, and drying conditions, this liquid extract is batch-adjusted at the concentration stage to a defined marker window prior to release. The extraction ratio is controlled at 4:1 to 5:1 dry root to final liquid extract (w/w), and the material is not diluted with inert thickeners unless specified in a co-processed grade.

    What Marker Compounds and Pharmacopoeial Limits Govern Release?

    Release specifications are aligned with relevant pharmacopoeial monographs for rhubarb extract. Total anthraquinones, calculated as rhein, are controlled at ≥5.0% w/w of the liquid extract, with individual HPLC markers set at rhein ≥1.2% w/w, emodin ≥0.8% w/w, chrysophanol ≥0.5% w/w, and aloe-emodin ≥0.3% w/w. Sennoside content, determined by HPLC using a method adapted from USP <621>, is controlled within 1.0–3.0% w/w for formulations where laxative action is the primary indication. Heavy metal limits follow USP <231>: lead <5.0 ppm, arsenic <2.0 ppm, cadmium <1.0 ppm, and mercury <0.1 ppm. Microbial purity is governed by USP <61> and USP <62>: total aerobic microbial count <1000 CFU/g, total combined yeast and mold <100 CFU/g, and absence of *Escherichia coli* and *Salmonella* species in a 10 g sample. The pH specification is 4.0–6.0 for neat liquid. Analytical method validation for release testing follows ICH Q2(R1) parameters. HPLC system suitability requires resolution of at least 1.5 between rhein and emodin peaks, tailing factor ≤2.0, and relative standard deviation ≤2.0% across five replicate injections of the standard solution. Forced degradation studies conducted under ICH Q1A(R2) conditions show that the marker profile is most sensitive to alkaline hydrolysis and photodegradation, with acid hydrolysis and thermal stress producing <5.0% total anthraquinone loss. The limit of detection for individual anthraquinones is 0.05% w/w, and the limit of quantitation is 0.10% w/w.
    ParameterSpecification LimitTest Method
    AppearanceDark brown to reddish-brown viscous liquidPh. Eur. 2.2.1
    Total solids25.0–30.0% w/wPh. Eur. 2.2.32
    Relative density1.100–1.150 g/cm³ at 25°CPh. Eur. 2.2.5
    Total anthraquinones≥5.0% w/w as rheinHPLC, USP <621>
    Rhein≥1.2% w/wHPLC, USP <621>
    Emodin≥0.8% w/wHPLC, USP <621>
    Chrysophanol≥0.5% w/wHPLC, USP <621>
    Aloe-emodin≥0.3% w/wHPLC, USP <621>
    Sennosides1.0–3.0% w/wHPLC, USP <621>
    Lead<5.0 ppmAAS, USP <231>
    Arsenic<2.0 ppmAAS, USP <231>
    Cadmium<1.0 ppmAAS, USP <231>
    Mercury<0.1 ppmCold vapour AAS, USP <231>
    TAMC<1000 CFU/gUSP <61>
    TYMC<100 CFU/gUSP <61>
    E. coli / SalmonellaAbsent in 10 gUSP <62>
    Ethanol residue<0.5% w/wHeadspace GC
    pH4.0–6.0Ph. Eur. 2.2.3
    Storage2–8°C, protected from light
    Tablet manufacture using this liquid extract requires carrier adsorption prior to granulation because the extract's water activity (aw 0.75–0.82) promotes caking and die-filling inconsistency when added directly to a powder blend. Fluid-bed spray granulation onto microcrystalline cellulose or pregelatinized starch as substrate, with inlet air temperature controlled at 55–65°C and extract feed rate of 15–25 g/min per kg of carrier, produces free-flowing granules with residual moisture of 3.0–5.0% w/w. Compression on a rotary tablet press using 8 mm concave tooling is feasible at a compression force of 25–40 kN when the granulation is lubricated with 0.5% w/w magnesium stearate and 0.5% w/w colloidal silicon dioxide. Tablet hardness of 5–8 kP and friability ≤0.5% per USP <1216> are achievable. Formulations exceeding 15.0% w/w liquid extract solids on a dry basis exhibit disintegration times beyond 30 minutes unless croscarmellose sodium is incorporated at 3.0–5.0% w/w as a superdisintegrant. Direct compression is not recommended at liquid loadings above 12% w/w because granule flowability deteriorates below a Carr Index threshold of 25. Where enteric protection is required for ruminant delivery, a methacrylic acid copolymer coating applied to a 4–5% weight gain in a side-vented coating pan provides pH-triggered release above pH 6.0.

    Injection-Grade Processing and Endotoxin Control Restrictions

    Formulation into injectables is constrained by the extract's tannin content, which complexes with proteins and may precipitate when pH falls below 3.5. Aqueous dilution to 10–20% v/v of the neat liquid in Water for Injection requires pH adjustment to 4.5–5.5 with 0.1 M sodium citrate buffer, followed by pre-filtration through a 0.45 μm membrane and terminal sterilizing-grade filtration through a 0.22 μm polyethersulfone membrane. Autoclaving of the final filled product is generally avoided because steam sterilization at 121°C for 15 minutes degrades total anthraquinones by 12–18%; aseptic filtration is the preferred route for terminally sterilized-in-place injectable formats. Endotoxin limits for veterinary injectable products are typically set at <0.5 EU/mL for intravenous administration and <5.0 EU/mL for intramuscular or subcutaneous routes, referencing Ph. Eur. 5.1.10 guidance. The extract itself is specified at <0.5 EU/mg of solids by kinetic chromogenic LAL per USP <85>. Because anthraquinone stability is light-sensitive, filled ampoules or vials require amber glass conforming to USP <660> Type I or Type II and nitrogen headspace purging. Under these conditions the marker profile remains within specification for 24 months at 2–8°C.

    When the Extract Is Co-Processed into Capsules, Powders, and Granules

    For hard capsule filling, the liquid extract is adsorbed onto a porous carrier—maltodextrin DE 10–15, silica-alumina, or pregelatinized starch—at a ratio of 1:1 to 1:1.5 w/w. The resulting powder should exhibit a Carr Index ≤20 and Hausner ratio ≤1.20 to ensure reproducible fill weight on automatic capsule-filling equipment with tamping pins. Liquid-filled hard capsules are an alternative; however, the extract's residual aqueous-ethanol vehicle is compatible with gelatine shells only when the fill formulation contains at least 35% w/w of a non-aqueous solvent such as medium-chain triglycerides or propylene glycol, otherwise shell softening and seal failure occur. Powder dosage forms are produced by spray-drying the liquid extract onto maltodextrin or gum acacia, yielding an amorphous powder with typical median particle size (D50) of 80–120 μm. Granulation for oral administration to livestock is performed in a top-spray fluid-bed processor using a binder solution of hydroxypropyl methylcellulose 5 cps at 5.0% w/w, with target granules retained between 500 μm and 1000 μm sieves. For granule products intended for drinking-water administration, a wetting agent such as polysorbate 80 at 0.1–0.5% w/w is incorporated to reduce surface tension and ensure rapid dispersion.
    Dosage FormKey Process StepCritical ParameterTarget Range
    TabletsFluid-bed spray granulationInlet air temperature55–65°C
    TabletsRotary compressionCompression force25–40 kN
    CapsulesPowder adsorptionCarr Index≤20
    CapsulesLiquid-filled shellNon-aqueous solvent fraction≥35% w/w
    InjectablesSterile filtrationMembrane pore size0.22 μm
    PremixCarrier sprayingMarker CV<5.0%
    Oral solutionsDilution and bufferingpH4.0–5.5
    PowdersSpray dryingMedian particle size D5080–120 μm
    For medicated premixes intended for feed incorporation at 0.5–2.0 kg per tonne, the liquid extract is sprayed onto a carrier selected from corn cob meal, wheat bran, or precipitated silica. Uniform distribution requires a coefficient of variation below 5.0% for the marker anthraquinone across 10 sample points per batch, determined by HPLC following solid-phase extraction. Mixing validation follows the FDA guidance for medicated feed premises, with recovery of the marker between 90% and 110% of theoretical at each sampling location. Oral solutions and drenches are prepared by diluting the neat extract to a working concentration of 1.0–5.0% w/w total anthraquinones with deionized water, propylene glycol, or glycerine; pH is maintained at 4.0–5.5 with 0.1 M citrate buffer to prevent aglycone precipitation. Neat extract viscosity at 25°C is specified as 500–1500 mPa·s measured on a Brookfield RVT viscometer with spindle 2 at 20 rpm, which dictates peristaltic or gear-pump transfer rather than centrifugal pumps in production. Storage above 25°C or exposure to direct sunlight accelerates dimerization of anthraquinone aglycones, reducing marker content by up to 10% over 12 months; opaque HDPE drums with tamper-evident seals are therefore required.

    Batch-to-Batch Marker Variability Is Reduced by the Liquid Standardization Route

    Three primary differences separate this liquid extract from alternative rhubarb-derived ingredients. First, lot-to-lot marker variability is reduced through in-process standardization: HPLC batch records for six consecutive production lots show a total anthraquinone coefficient of variation of 3.8%, whereas crude rhubarb powder typically exhibits 30–50% variability due to seasonal, geographical, and post-harvest handling factors. Second, the liquid matrix enables direct metered dosing into continuous granulation and liquid-filling lines, eliminating dust-handling losses and electrostatic adhesion observed with micronized powdered extracts; however, the liquid form carries a 12-month recommended-use period from the date of manufacture, compared with 36 months for dried spray-dried extract stored at controlled room temperature over desiccant. Third, the natural anthraquinone profile includes rhein, emodin, chrysophanol, aloe-emodin, and physcion in proportions consistent with pharmacopoeial rhubarb, whereas synthetic alternatives typically supply a single compound such as rhein or emodin alone, which does not replicate the full glycoside–aglycone fraction. Published controlled feeding studies in swine and poultry for this specific liquid extract configuration are limited; species-specific pharmacokinetic verification is required prior to registration. Storage and handling incompatibilities merit explicit documentation. The extract should not be combined with strong alkalizing agents above pH 7.0 because anthraquinone aglycones undergo oxidative degradation to inactive anthrones under alkaline conditions. Contact with iron or copper equipment is contraindicated; anthraquinones chelate divalent metals, forming insoluble complexes that darken the liquid and reduce bioavailable marker content. Stainless steel 316L or glass-lined vessels are required for all processing steps. At relative humidity above 60%, open handling of spray-dried intermediate powder initiates clumping within 20 minutes; closed transfer systems with nitrogen purge are recommended for powder-filling operations.
    Top